substance p has been researched along with Diabetes Mellitus, Adult-Onset in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.00) | 18.2507 |
| 2000's | 8 (32.00) | 29.6817 |
| 2010's | 11 (44.00) | 24.3611 |
| 2020's | 5 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Block, M; Gharraee, N; Goslen, KH; Kavanagh, K; Lacy, JL; Levick, SP; Meléndez, GC; Whitfield, J; Widiapradja, A | 1 |
| Issar, T; Krishnan, AV; Kwai, N; Markoulli, M; Pisarcikova, J; Poynten, AM; Tummanapalli, SS; Willcox, MDP | 1 |
| Cai, J; Fang, X; Gong, X; Ren, Y; Song, E | 1 |
| Baek, SM; Hong, HS; Kim, K; Kim, S; Son, Y; Yu, SY | 1 |
| Bhadada, SK; Malik, A; Morya, RK; Rana, SV; Saha, S; Singh, PK | 1 |
| Park, KS; Um, J; Yu, J | 1 |
| Duong, CL; Karras, J; Kim, J; Lum, E; Markoulli, M; Tolentino, JB; You, J | 1 |
| Karamichos, D; Ma, JX; Priyadarsini, S; Rowsey, TG | 1 |
| Choi, S; Jung, N; Kim, D; Lee, SH; Park, KS; Son, Y; Um, J | 1 |
| Balemba, O; Gericke, M; Kappmeyer, AJ; Schmalz, JT; Stenkamp-Strahm, CM | 1 |
| Balemba, OB; Gericke, M; Horton, S; Kappmeyer, AJ; Nyavor, YE; Stenkamp-Strahm, CM | 1 |
| Albiero, M; Avogaro, A; Canal, F; Cappellari, R; Carnelli, F; Dang, Z; Emanueli, C; Fadini, GP; Falco, A; Furlan, A; Lorusso, B; Madeddu, P; Maselli, D; Ou, K; Paccagnella, A; Paiola, E; Quaini, F; Rodriguez-Arabaolaza, I; Rosa, F; Sambataro, M; Sangalli, E; Seganfreddo, E; Specchia, C; Spinetti, G | 1 |
| Abdul, AM; Ackermann, PW; Ahmed, AS; Ahmed, M; Hart, DA; Hewitt, C; Li, J; Östenson, CG; Salo, PT | 1 |
| Liu, Y; Qiu, GQ; Wang, R; Zhang, M; Zhao, XR | 1 |
| Chikama, T; Chikamoto, N; Ishimitsu, T; Kamiya, A; Nishida, T; Yamada, N | 1 |
| Fu, J; Li, G; Liu, B; Liu, L; Liu, P; Liu, X; Wu, B | 1 |
| Byrd, JS; Elsayed, R; Marshall, GD; Minor, DS | 1 |
| Bianchi, C; Chu, LM; Clements, RT; Dobrilovic, N; Feng, J; Fingleton, JG; Liu, Y; Sellke, FW; Singh, AK | 1 |
| Chae, SL; Kim, JC; Lee, IG | 1 |
| Galkowska, H; Karnafel, W; Olszewski, WL; Rosinski, G; Wojewodzka, U | 1 |
| Furuta, T; Hishida, A; Ikuma, M; Iwasaki, H; Kajimura, M; Kanaoka, S; Osawa, S | 1 |
| Fujimoto, K; Iwakiri, R | 1 |
| Dhanasekaran, S; Mensah-Brown, E; Morrison, JF; Shaffiullah, M; Sheen, R; Shehab, S | 1 |
| Grouzmann, E; Lacroix, JS; Landis, BN; Monod, M | 1 |
| Dorsey, DA; Roth, KA; Schmidt, RE | 1 |
3 trial(s) available for substance p and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Substance P induces sympathetic immune response in the contralateral eye after the first eye cataract surgery in type 2 diabetic patients.
Topics: Aqueous Humor; Cataract; Cytokines; Diabetes Mellitus, Type 2; Humans; Immunity; Prospective Studies; Substance P; Vascular Endothelial Growth Factor A | 2020 |
[Effect of Zhizhuwan on gastrointestinal peptide concentrations in plasma of diabetic gastroenteropathy with constipation patients].
Topics: Aged; Constipation; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Female; Gastrointestinal Diseases; Gastrointestinal Hormones; Gastrointestinal Motility; Humans; Male; Middle Aged; Substance P | 2008 |
Efficacy of substance P and insulin-like growth factor-1 peptides for preventing postsurgical superficial punctate keratopathy in diabetic patients.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Corneal Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Epithelium, Corneal; Female; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Oligopeptides; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Prospective Studies; Substance P; Treatment Outcome | 2009 |
22 other study(ies) available for substance p and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Replacement substance P reduces cardiac fibrosis in monkeys with type 2 diabetes.
Topics: Animals; Cardiomyopathies; Chlorocebus aethiops; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female; Fibrosis; Mice; Myocardium; Stroke Volume; Substance P; Ventricular Function, Left | 2023 |
A Comparative Study on the Diagnostic Utility of Corneal Confocal Microscopy and Tear Neuromediator Levels in Diabetic Peripheral Neuropathy.
Topics: Adult; Area Under Curve; Calcitonin Gene-Related Peptide; Cornea; Corneal Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Microscopy, Confocal; Middle Aged; Prospective Studies; ROC Curve; Substance P; Tears; Trigeminal Nerve Diseases | 2020 |
SP prevents T2DM complications by immunomodulation.
Topics: Animals; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Fatty Acids; Immunomodulation; Insulin Resistance; Male; Rats; Rats, Inbred OLETF; Substance P; Triglycerides | 2020 |
Angiotensin-Converting Enzyme Gene Polymorphism Influences Gastrointestinal Motility in Type 2 Diabetes Mellitus.
Topics: Alleles; Angiotensins; Diabetes Mellitus, Type 2; Female; Gastrointestinal Motility; Gene Frequency; Genotype; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Polymorphism, Genetic; Substance P | 2021 |
Substance P accelerates wound healing in type 2 diabetic mice through endothelial progenitor cell mobilization and Yes-associated protein activation.
Topics: Adaptor Proteins, Signal Transducing; Animals; Bone Marrow; Cell Cycle Proteins; Cell Movement; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Endothelial Progenitor Cells; Immunohistochemistry; Injections, Subcutaneous; Male; Mice; Neovascularization, Physiologic; Phosphoproteins; Platelet Endothelial Cell Adhesion Molecule-1; Random Allocation; Substance P; Wound Healing; YAP-Signaling Proteins | 2017 |
Corneal Nerve Morphology and Tear Film Substance P in Diabetes.
Topics: Case-Control Studies; Cornea; Corneal Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Eye Proteins; Female; Humans; Male; Microscopy, Confocal; Middle Aged; Nerve Fibers; Prospective Studies; Substance P; Tears; Trigeminal Nerve; Trigeminal Nerve Diseases | 2017 |
Unravelling the stromal-nerve interactions in the human diabetic cornea.
Topics: Biomarkers; Case-Control Studies; Cell Differentiation; Cells, Cultured; Coculture Techniques; Collagen; Corneal Diseases; Corneal Stroma; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Extracellular Matrix; Female; Fibroblasts; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Models, Biological; Neurons; Receptor, IGF Type 1; Substance P; Tubulin | 2017 |
Substance P preserves pancreatic β-cells in type 1 and type 2 diabetic mice.
Topics: Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Hyperglycemia; Immunomodulation; Insulin-Secreting Cells; Male; Mice, Inbred NOD; Pancreatic Stellate Cells; Substance P | 2018 |
High-fat diet ingestion correlates with neuropathy in the duodenum myenteric plexus of obese mice with symptoms of type 2 diabetes.
Topics: Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Duodenum; Mice; Mice, Inbred C57BL; Mice, Obese; Myenteric Plexus; Neurons; Nitric Oxide Synthase; Obesity; Substance P; Vasoactive Intestinal Peptide | 2013 |
Prolonged high fat diet ingestion, obesity, and type 2 diabetes symptoms correlate with phenotypic plasticity in myenteric neurons and nerve damage in the mouse duodenum.
Topics: Animals; Apoptosis; Diabetes Mellitus, Type 2; Diet, High-Fat; Duodenum; Enteric Nervous System; Insulin Resistance; Mice; Mice, Inbred C57BL; Myenteric Plexus; Neurodegenerative Diseases; Neurons; Nitric Oxide Synthase; Obesity; Substance P | 2015 |
Sensory neuropathy hampers nociception-mediated bone marrow stem cell release in mice and patients with diabetes.
Topics: Animals; Cross-Sectional Studies; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Hematopoietic Stem Cells; Humans; Mice; Nociception; Sensory Receptor Cells; Substance P | 2015 |
Compromised Neurotrophic and Angiogenic Regenerative Capability during Tendon Healing in a Rat Model of Type-II Diabetes.
Topics: Achilles Tendon; Animals; Brain-Derived Neurotrophic Factor; Diabetes Mellitus, Type 2; Disease Models, Animal; Gene Expression; Male; Neovascularization, Physiologic; Nerve Growth Factor; Rats; Rats, Wistar; Receptor, trkA; Receptor, trkB; Receptors, Neurokinin-1; Substance P; Tendon Injuries; Wound Healing | 2017 |
Substance P is associated with the development of obesity, chronic inflammation and type 2 diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; C-Reactive Protein; Cholesterol; Diabetes Mellitus, Type 2; Female; Humans; Insulin; Interleukin-6; Male; Middle Aged; Obesity; Substance P; Triglycerides; Uric Acid | 2011 |
DPP-4 inhibitors and angioedema: a cause for concern?
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypertension; Product Surveillance, Postmarketing; Substance P | 2011 |
Changes in microvascular reactivity after cardiopulmonary bypass in patients with poorly controlled versus controlled diabetes.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Aged; Arterioles; Cardiopulmonary Bypass; Coronary Artery Bypass; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Type 2; Disease Susceptibility; Endothelium, Vascular; Enzyme Induction; Female; Gene Expression Regulation; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Male; Microcirculation; Middle Aged; Muscle, Skeletal; Nitroprusside; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Substance P; Tyrosine; Vasoconstriction; Vasodilator Agents | 2012 |
Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inducing Agents; Antigens, CD34; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Endothelium, Vascular; Erythropoietin; Female; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Retinal Neovascularization; Severity of Illness Index; Stem Cells; Substance P; Vascular Endothelial Growth Factor A | 2006 |
Neurogenic factors in the impaired healing of diabetic foot ulcers.
Topics: Aged; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Type 2; Diabetic Foot; Epidermis; Female; GAP-43 Protein; Humans; Immunohistochemistry; Inflammation; Male; Middle Aged; Nerve Endings; Neurotrophin 3; Skin; Substance P; Ubiquitin Thiolesterase | 2006 |
A deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus.
Topics: Biomarkers; Cell Count; Diabetes Mellitus, Type 2; Female; Gastric Emptying; Gastric Mucosa; Humans; Immunohistochemistry; Male; Microscopy, Confocal; Myenteric Plexus; Neurons; Nitric Oxide Synthase Type I; Retrospective Studies; Substance P | 2006 |
Diabetic gastropathy and interstitial cells of Cajal: a clue for bringing understanding out of chaos?
Topics: Biomarkers; Cell Count; Diabetes Mellitus, Type 2; Gastric Mucosa; Humans; Immunohistochemistry; Microscopy, Confocal; Myenteric Plexus; Neurons; Nitric Oxide Synthase Type I; Substance P | 2006 |
Sensory and autonomic nerve changes in the monosodium glutamate-treated rat: a model of type II diabetes.
Topics: Aging; Animals; Autonomic Nervous System; Blood Glucose; Body Weight; Calcitonin Gene-Related Peptide; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Glucose Intolerance; Glucose Tolerance Test; Hot Temperature; Immunohistochemistry; Insulin; Insulin-Secreting Cells; Neurons, Afferent; Obesity; Organ Size; Pain Measurement; Physical Stimulation; Radioimmunoassay; Rats; Rats, Wistar; Receptors, Neurokinin-1; Sodium Glutamate; Substance P | 2008 |
Adverse effects of incretin therapy for type 2 diabetes.
Topics: Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Inflammation; Nasopharyngitis; Substance P | 2007 |
Immunohistochemical characterization of NPY and substance P containing nerve terminals in aged and diabetic human sympathetic ganglia.
Topics: Aged; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Ganglia, Sympathetic; Humans; Immunohistochemistry; Nerve Endings; Neurons; Neuropeptide Y; Substance P | 1992 |